We take a look at some of the exciting diabetes research developments announced in November 2025, and what the findings could mean for people living with or affected by diabetes.
The drug manufacturer Novo Nordisk has announced it will withdraw Levemir insulin in all forms by the end of 2026. Here, we look at what this means for people with diabetes who are affected, and what ...
The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...
Our research has provided the most detailed picture yet of how weight loss improves health. The findings offer important clues about how losing weight can help people with type 2 diabetes improve ...
Find out more about the remission weight loss programme which offers most people living with type 2 diabetes the best chance of going into remission.
We take a look at some of the exciting diabetes research developments announced in May, and what the findings could mean for people living with or affected by diabetes.
The Bukhman Foundation has today announced a historic £100 million pledge to fund groundbreaking research that will accelerate progress towards new treatments and a cure for type 1 diabetes. Save for ...
Our new data shows that an urgent intervention is needed in diabetes care and type 2 diabetes prevention to lower the number of people living with diabetes or prediabetes. Save for later Page saved!
Lung problems can be a complication of diabetes. Research into diabetes and lung problems is a new area. The information on this page tells you what we know so far. Find out the symptoms of different ...
On World Diabetes Day last year, we became one of the first organisations in the UK to sign the global pledge to end diabetes stigma and discrimination, which has now been signed by over 330 ...
Some people who have followed a Mediterranean diet have lost weight and gone into type 2 diabetes remission. Find out more here.
We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.